argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
646.60
+9.04 (1.42%)
Aug 13, 2025, 4:00 PM - Market closed
argenx SE Market Cap
argenx SE has a market cap or net worth of $39.49 billion as of August 14, 2025. Its market cap has increased by 32.33% in one year.
Market Cap
39.49B
Enterprise Value
35.61B
1-Year Change
32.33%
Ranking
Category
Stock Price
$646.60
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $39.49B, an increase of 6,290.01%. That is a compound annual growth rate of 65.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 39.46B | 7.31% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |